Metraipolis › archive › dc_cf87501a9bf1

Safety, Tolerability, and Pharmacokinetics of Mirvetuximab Soravtansine in Chinese Patients With Folate Receptor α-Positive Advanced Ovarian Cancer — Europe PMC PMID:42165281

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42165281
DOI
10.1002/cam4.71704
License (as archived)
solo-consultazione
Archived
2026-11-02T22:04:43.733Z
SHA-256 of the archived text
f77045935440339417cf93dfd0373da266b8360049ee38ccf599fc4146cc4974
Stable URL of this page
https://metraipolis.com/documento/dc_cf87501a9bf1

How to cite

Safety, Tolerability, and Pharmacokinetics of Mirvetuximab Soravtansine in Chinese Patients With Folate Receptor α-Positive Advanced Ovarian Cancer — Europe PMC PMID:42165281 — Europe PMC (en), https://europepmc.org/article/MED/42165281 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cf87501a9bf1 (Metraipolis archive dc_cf87501a9bf1, sha256 f77045935440339417cf93dfd0373da266b8360049ee38ccf599fc4146cc4974)
BibTeX
@misc{dccf87501a9bf1,
  title = {Safety, Tolerability, and Pharmacokinetics of Mirvetuximab Soravtansine in Chinese Patients With Folate Receptor α-Positive Advanced Ovarian Cancer — Europe PMC PMID:42165281},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42165281},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cf87501a9bf1; sha256 f77045935440339417cf93dfd0373da266b8360049ee38ccf599fc4146cc4974},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42165281. Agents can read the archived copy with the MCP tool read_document.